Rezultaty - Jean‐Pierre Bronowicki
- Rezultaty 1 - 20 Rezultaty od 55
- Idź do następnej strony
-
1
-
2
-
3
-
4
Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study od Shannon Ferrante, Jagpreet Chhatwal, Clifford A. Brass, Antoine C. El Khoury, Fred Poordad, Jean-Pierre Bronowicki, Elamin H. Elbasha
Wydane 2013Artigo -
5
-
6
Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin od M. Diago, Mitchell L. Shiffman, Jean‐Pierre Bronowicki, Stefan Zeuzem, M. Rodríguez‐Torres, S. Chris Pappas, Andreas Tietz, David R. Nelson
Wydane 2010Artigo -
7
The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges od Marie Müller, Vincent Haghnejad, Marion Schaefer, Guillaume Gauchotte, Bénédicte Caron, Laurent Peyrin‐Biroulet, Jean-Pierre Bronowicki, Cindy Neuzillet, Anthony Lopez
Wydane 2022Revisão -
8
Rate of natural disease progression in patients with chronic hepatitis C od Jean-Pierre Zarski, J. Mc Hutchison, Jean-Pierre Bronowicki, Nathalie Stürm, Richard Garcia‐Kennedy, Enkelejda Hodaj, Brenda Truta, Teresa L. Wright, Robert G. Gish
Wydane 2003Artigo -
9
Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year Study of 127 French Patients od Jean‐Pierre Bronowicki, Denis Vetter, F Dumas, Karim Boudjéma, Robert Bader, Anne-Marie Weiss, Jean-Jacques Wenger, P Boissel, Marc‐André Bigard, Michel Doffoël
Wydane 1994Artigo -
10
Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections od Graham R. Foster, Christophe Hézode, Jean‐Pierre Bronowicki, Giampiero Carosi, Ola Weiland, Lieselotte Verlinden, Rolf van Heeswijk, Ben Van Baelen, Gastón Picchio, Maria Beumont
Wydane 2011Artigo -
11
Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France od Jean‐Baptiste Chevaux, Abdelbasset Nani, Abderrahim Oussalah, Véronique Venard, Mouni Bensenane, Arthur Belle, Jean‐Louis Guéant, Marc‐André Bigard, Jean-Pierre Bronowicki, Laurent Peyrin–Biroulet
Wydane 2009Artigo -
12
Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection od Olivier Hermine, François Lefrère, Jean‐Pierre Bronowicki, Xavier Mariette, Katayoun Jondeau, Virginie Eclache-Saudreau, B Delmas, Françoise Valensi, P. Cacoub, Christian Bréchot, Bruno Varet, Xavier Troussard
Wydane 2002Artigo -
13
Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy od Jean‐Pierre Bronowicki, Véronique Venard, C. Botté, Nathalie Monhoven, Isabelle Gastin, Laurence Choné, Hervé Hudziak, Bertrand Rhin, Christophe Delanoë, Alain Lefaou, Marc‐André Bigard, P Gaucher
Wydane 1997Artigo -
14
Primary Lymphoma of the Liver: Clinical–Pathological Features and Relationship With Hcv Infection in French Patients od Jean‐Pierre Bronowicki, Catherine Bineau, Pierre Feugier, Olivier Hermine, Nicole Brousse, Frédéric Oberti, Marie-Christine Rousselet, Sébastien Dharancy, Philippe Gaulard, Jean–François Fléjou, Dominique Cazals–Hatem, Eric Labouyrie
Wydane 2003Artigo -
15
869b Simeprevir (TMC435) With Peginterferon/Ribavirin for Treatment of Chronic HCV Genotype 1 Infection in Patients Who Relapsed After Previous Interferon-Based Therapy: Results Fr... od Eric Lawitz, Xavier Forns, Stefan Zeuzem, Edward Gane, Jean‐Pierre Bronowicki, Pietro Andreoné, Andrzej Horban, Ashley Brown, Monika Peeters, Oliver Lenz, Sivi Ouwerkerk‐Mahadevan, Ronald Kalmeijer, Maria Beumont‐Mauviel
Wydane 2013Artigo -
16
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+) od Vincent Leroy, Peter Angus, Jean‐Pierre Bronowicki, Gregory J. Dore, Christophe Hézode, Stephen Pianko, Stanislas Pol, Katherine Stuart, Edmund Tse, Fiona McPhee, Rafia Bhore, M.J. Jimenez-Exposito, Alexander Thompson
Wydane 2016Artigo -
17
Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3... od Jason Grebely, Stefan Mauss, Ashley Brown, Jean‐Pierre Bronowicki, Massimo Puoti, David Wyles, Macky Natha, Yanni Zhu, Junming Yang, Bruce Kreter, Diana M. Brainard, Chohee Yun, Val Carr, Gregory J. Dore
Wydane 2016Artigo -
18
Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy od Stella Maris Martínez, Juliette Foucher, Jean-Marc Combis, Sophie Métivier, Maurizia Rossana Brunetto, Dominique Capron, Marc Bourlière, Jean‐Pierre Bronowicki, Thông Dao, M. Maynard-Muet, Damien Lucidarme, Wassil Merrouche, Xavier Forns, Victor de Lédinghen
Wydane 2012Artigo -
19
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B od Patrick Marcellin, Herve Momméja-Marin, Stephen L. Sacks, George Lau, D. Séréni, Jean‐Pierre Bronowicki, Brian Conway, Christian Trépo, Robert M. Blum, Byung Chul Yoo, Elsa Mondou, J. Sorbel, A. Lynn Snow, Franck Rousseau, Hyo‐Suk Lee
Wydane 2004Artigo -
20
Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial od Mark S. Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki, Tarik Asselah, Jean‐Michel Pawlotsky, Stephen D. Shafran, Stanislas Pol, Stefan Mauss, Dominique Larrey, Yakov Datsenko, Jerry O. Stern, George Kukolj, Joseph Schérer, Gerhard Nehmiz, Gerhard Steinmann, Wulf O. Böcher
Wydane 2013Artigo
Narzędzie wyszukiwania:
Podobne hasła
Medicine
Internal medicine
Gastroenterology
Virus
Hepatitis C virus
Immunology
Hepatitis C
Ribavirin
Biology
Hepatocellular carcinoma
Virology
Cirrhosis
Gene
Genotype
Oncology
Genetics
Pathology
Boceprevir
Adverse effect
Alternative medicine
Cancer
Chronic hepatitis
Cohort
Hepatitis B virus
Physics
Placebo
Sofosbuvir
Surgery
Biochemistry
Daclatasvir